Robert D. Stenzel
Robert Stenzel joined Ropes & Gray’s health care practice group in 2022. Robert’s practice focuses on representing hospitals and healthcare organizations in contesting adverse agency actions and in disputes involving Medicare reimbursement rules and decisions. Robert also provides regulatory guidance to pharmaceutical developers and distributors.
Robert also maintains a pro bono practice assisting lawful permanent residents applying for citizenship and providing guidance on changing government identification for transgender and non-binary individuals.
Prior to joining Ropes & Gray, Robert served as the senior articles editor on the Maryland Journal of Health Care Law and Policy. Robert has done research on stakeholder perceptions of microbiome testing and regulations, and state regulation of access to newborn screening data. Prior to law school, Robert earned his master of bioethics at the Johns Hopkins Bloomberg School of Public Health and Berman Institute of Bioethics.
- Rob Stenzel, “The Trump Administration Wants to Block Cities’ Plans to Cut Drug Overdoses,” Vice (August 31, 2018)
- Co-author, “Type 1 Diabetes: Urinary Proteomics and Protein Network Analysis Support Perturbation of Lysosomal Function,” Theranostics, Volume 7 (July 2017)
- JD, University of Maryland Francis King Carey School of Law, 2022; Senior Articles Editor, Maryland Journal of Health Care Law and Policy
- MBE, Johns Hopkins Bloomberg School of Public Health and Berman Institute of Bioethics, 2018; Thesis: The Opioid Crisis: What Does Justice Require of Drug Policy?
- BS (Biology), University of Maryland, Baltimore County, 2013
Admissions / Qualifications
- Not admitted in the District of Columbia. Supervised by Ropes & Gray LLP attorneys who are members of the District of Columbia Bar.
- Maryland, 2022